Recruitment of a post-doc and on the ANR project nanosqualonc:
Nanovectorization by squalenization of anticancer agents for neoplasias with fusion
oncogenes
Abstract: Terpenoids (or isoprenoïds) are a group of natural compounds that are
extraordinary diverse in chemistry, structure and function. Surprisingly, they have never been
used previously in the nanomedicine field for drug delivery and targeting purposes. Our aim
in this research project is to use the extraordinary capacity of self-assembling of squalenic
derivatives in aqueous medium as nanoparticles for the nanoformulation of macromolecules
(siRNA) or small molecules (ifosfamide) able to improve the treatment of several solid
tumors where junction oncogenes are involved, such as the papillary thyroid carcinoma
(PTC), the Ewing sarcoma (EWS) and prostate cancer (PC).
Requested profile for the post-doctoral researcher: We wish to recruit for 24 months a
post-doctoral researcher having acquired a solid experiment in these fields. The candidate
should have a strong background in molecular and cellular biology as well as in animal
experiments. He (she) will assess the efficiency of terpenoylated siRNA in VCaP and NCI-
H660 cells for the prostate cancer, TPC-1 and BHP10-3 cells for papillary thyroid carcinoma
and A673 cells for Ewing sarcoma. Also, the anticancer activity of the siRNA and
Oxazaphosphorine terpenoyl nanomedicines will be studied in vivo in animal models by
following the tumour growth.
Contact: The candidates should send their resume and interested letter to: Dr. Liliane
MASSADE, mail: liliane.massade@igr.fr, Institut Gustave Roussy, UMR 8203 CNRS, PR2,
114 rue Edouard Vaillant, 94805 Villejuif Cedex
Contract Start Date: 1st October 2011